Joseph M. Feczko, MD

Joseph Feczko, MD is Board Certified in internal medicine and infectious disease. Following time in private practice, Dr. Feczko served in leadership roles with Glaxo and Pfizer, retiring in 2009 as Senior Vice President and Chief Medical Officer for Pfizer. Dr. Feczko is currently the Chairman of the Board of Directors of Cardoz Pharmaceuticals AB (Stockholm, Sweden), a member of the Board of Directors of Keryx Biopharmaceuticals, Inc., and a member of the Supervisory Board of Amsterdam Molecular Therapeutics based in The Netherlands, and a member of the Supervisory Board of Cytheris, a biotechnology company based in France." Dr. Feczko previously served one term the Board of Directors of Research!America and is currently a member of the Board of Directors of the Foundation for the National Institutes of Health, the International Longevity Center, the New York Academy of Medicine, the Accordia Global Health Foundation, and the Technical Expert Committee for Trachoma on the International Trachoma Initiative of the Task Force for Global Health. Dr. Feczko earned his Doctor of Medicine degree at Abraham Lincoln School of Medicine, University of Illinois, Chicago.